107 results
8-K
EX-99.1
CRVO
CervoMed Inc
7 Feb 24
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
4:06pm
Board of Directors (Board) and as Chair of the Board. Dr. Boger is an innovative scientist and highly successful business executive who brings extensive
8-K
EX-99.2
CRVO
CervoMed Inc
7 Feb 24
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
4:06pm
efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products
8-K
EX-99.1
CRVO
CervoMed Inc
5 Jan 24
CervoMed to Participate in the Emerging Growth Conference 66
4:05pm
efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products
8-K/A
EX-99.3
8s4yhucjh
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
PRRN14A
9ibg 03ibn35oa
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
9t2pwj0g45etvaw
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
vi1qhhixj2ale
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
2pxm0
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
3j1 fl08u4
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
PREC14A
cx3q9 lu7
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
DFAN14A
3crd1znefdvxu6cmt6
18 Nov 22
Additional proxy materials by non-management
11:02am
8-K
EX-99.1
ujll9xzh69
16 Aug 22
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:21pm
8-K
7ekmtto9k6mnorcm4z
27 Jul 22
Other Events
7:30am
8-K
EX-99.1
y8ktkagez07
27 Jul 22
Other Events
7:30am
424B5
jy35yw3
22 Jul 22
Prospectus supplement for primary offering
4:15pm